Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice. Percées du letermovir lors du programme français Named Patient : intérêt du suivi des concentrations sanguines en pratique clinique

0 avis

Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice. Percées du letermovir lors du programme français Named Patient : intérêt du suivi des concentrations sanguines en pratique clinique

Archive ouverte

Edité par CCSD ; Oxford University Press (OUP) -

International audience

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure

Archive ouverte | Muller, Clotilde | CCSD

International audience

ASPICov: An automated pipeline for identification of SARS-Cov2 nucleotidic variants

Archive ouverte | Tilloy, Valentin | CCSD

International audience. ASPICov was developed to provide a rapid, reliable and complete analysis of NGS SARS-Cov2 samples to the biologist. This broad application tool allows to process samples from either capture o...

Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD)

Archive ouverte | Tilloy, Valentin | CCSD

International audience

Chargement des enrichissements...